Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ES09.03 The Role of Biomarkers for Immunotherapy in the Adjuvant and Neoadjuvant Setting

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.08.742Source: DataRank Database

ES09.03 The Role of Biomarkers for Immunotherapy in the Adjuvant and Neoadjuvant Setting is a research paper published in Journal of Thoracic Oncology (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: bronzeTopics (16)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

F. Ghiringhelli

Live enrichment

PubMed:30945415 OpenAlex:https://openalex.org/W3206117247

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jto.org/article/S1556086421031658/pdf

publisherhttp://www.jto.org/article/S1556086421031658/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1556086421031658?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1556086421031658?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtho.2021.08.742

Fields of Study

Cancer Immunotherapy and BiomarkersLymphoma Diagnosis and TreatmentColorectal Cancer Treatments and Studies

Keywords

MedicineAtezolizumabOncologyNivolumabAdjuvantInternal medicineNeoadjuvant therapyChemotherapyImmunotherapyClinical trialBiomarkerCancerBreast cancer

Sustainable Development Goals

SDG 0: Good health and well-being

ES09.03 The Role of Biomarkers for Immunotherapy in the Adjuvant and Neoadjuvant Setting

FAIR Checklist

Authors (1)

Open Access

Topics